IDXG insider filings

INTERPACE BIOSCIENCES, INC. — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-20. Screen IDXG transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for IDXG between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — INTERPACE BIOSCIENCES, INC.

FiledFormInsiderReported transactionsSource
2026-08-204Burnell Thomas W. — CEO, President & Chairman, DirectorOption exercise (M): 1,966,763 @ $0 · Tax withholding (F): 581,718 @ $1.61 · Grant/award (A): 1,966,763 (derivative) @ $0 · Option exercise (M): 1,966,763 (derivative) @ $0 · Grant/award (A): 554,018 (derivative) @ $0EDGAR
2026-08-204AGGARWAL VIJAY — DirectorGrant/award (A): 69,252 (derivative) @ $0EDGAR
2026-08-204KEEGAN JOSEPH D — DirectorGrant/award (A): 69,252 (derivative) @ $0EDGAR
2026-08-204Rocca Fortunato R. — DirectorGrant/award (A): 69,252 (derivative) @ $0EDGAR
2026-08-204McCarthy Christopher — CFO & COOOption exercise (M): 277,009 @ $0 · Grant/award (A): 554,018 (derivative) @ $0 · Option exercise (M): 277,009 (derivative) @ $0 · Grant/award (A): 277,009 (derivative) @ $0EDGAR
2026-08-204SULLIVAN STEPHEN J — DirectorGrant/award (A): 69,252 (derivative) @ $0EDGAR
2026-02-1741315 Capital II, L.P. — 10% ownerConversion (C): 9,405,941 @ $2.02 · Conversion (C): 19,000 (derivative) @ $0EDGAR
2026-02-044Ampersand 2018 Limited Partnership — 10% ownerConversion (C): 13,861,386 @ $2.02 · Conversion (C): 28,000 (derivative) @ $0EDGAR
2025-04-254McCarthy Christopher — Chief Financial OfficerOption exercise (M): 7,556 @ $0 · Option exercise (M): 1,095 @ $0 · Option exercise (M): 7,556 @ $0 · Option exercise (M): 6,045 @ $0 · Option exercise (M): 15,112 @ $0 · Option exercise (M): 1,111 @ $0EDGAR
2024-10-1541315 Capital II, L.P. — 10% ownerDisposition to issuer (D): 19,000 (derivative) · Grant/award (A): 19,000 (derivative)EDGAR
2024-10-154Ampersand 2018 Limited Partnership — 10% ownerDisposition to issuer (D): 28,000 (derivative) · Grant/award (A): 28,000 (derivative)EDGAR
2024-02-064McCarthy Christopher — Chief Financial OfficerGrant/award (A): 10,000 @ $0EDGAR
2023-08-014McCarthy Christopher — Chief Financial OfficerGrant/award (A): 25,000 @ $0EDGAR
2022-02-024AGGARWAL VIJAY — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2021-05-254Burnell Thomas W. — President & CEO, DirectorPurchase (P): 10,855 @ $8.68EDGAR
2021-03-014Kamin Peter — 10% ownerPurchase (P): 14,946 @ $3.17 · Purchase (P): 16,360 @ $3.08 · Purchase (P): 14,874 @ $3.17 · Purchase (P): 14,726 @ $3.08 · Purchase (P): 8,333 @ $3.17 · Purchase (P): 8,252 @ $3.08 · +2 moreEDGAR
2021-02-024Gorman Robert J. — DirectorGrant/award (A): 12,438 @ $4.02EDGAR
2020-12-024STOVER JACK EGrant/award (A): 43,750 (derivative) @ $0EDGAR
2020-12-024Burnell Thomas W. — President and CEO, DirectorGrant/award (A): 100,000 @ $0 · Grant/award (A): 125,000 @ $0EDGAR

Recent 8-K events — INTERPACE BIOSCIENCES, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-178-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-278-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-268-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-218-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-018-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-208-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR

Registration filings — INTERPACE BIOSCIENCES, INC.

Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=IDXG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs